Facilitated By

San Antonio Medical Foundation

ONCOGENE LMO1 AS A NOVEL DIFFERENTIATION AND PROGNOSTIC MARKER FOR NEUROENDOCRINE LUNG CANCERS

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Du,Liqin
Funded by
PETER BRADLEY CARLSON CHARITABLE TRUST
Research Start Date
Status
Inactive
Basic Research
Cancer